Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$18.97 USD
-0.23 (-1.20%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $18.98 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Sabra Healthcare (SBRA) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$18.14 | $21.00 | $15.00 | -4.38% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for Sabra Healthcare comes to $17.86. The forecasts range from a low of $15.00 to a high of $21.00. The average price target represents a decline of 6.98% from the last closing price of $19.20.
Analyst Price Targets (11)
Broker Rating
Sabra Healthcare currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms. The current ABR compares to an ABR of 2.14 a month ago based on 14 recommendations.
Of the 14 recommendations deriving the current ABR, seven are Strong Buy, representing 50% of all recommendations. A month ago, Strong Buy represented 42.86%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 6 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 7 | 7 | 8 | 8 | 8 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.14 | 2.14 | 2.14 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/13/2024 | Not Identified | Not Identified | Hold | Strong Buy |
9/4/2024 | Truist Securities | Michael Lewis | Strong Buy | Strong Buy |
8/30/2024 | BMO Capital Markets | John P Kim | Hold | Hold |
8/26/2024 | Scotiabank | Nicholas Yulico | Hold | Hold |
8/20/2024 | Mizuho SecuritiesUSA | Vikram Malhotra | Strong Buy | Strong Buy |
8/9/2024 | JMP Securities | Aaron Hecht | Hold | Hold |
8/8/2024 | Wedbush Securities | Richard Anderson | Strong Buy | Strong Buy |
7/14/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/20/2024 | Robert W. Baird & Co. | Wesley Golladay | Hold | Hold |
5/28/2024 | Not Identified | Not Identified | Hold | Hold |
3/15/2024 | KeyBanc Capital Markets | Austin Wurschmidt | Hold | Hold |
1/30/2024 | Wells Fargo Securities | Connor Siversky | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 14 |
Average Target Price | $17.86 |
LT Growth Rate | 5.00% |
Industry | REIT and Equity Trust - Other |
Industry Rank by ABR | 86 of 253 |
Current Quarter EPS Est: | 0.36 |
SBRA FAQs
Sabra Healthcare REIT, Inc. (SBRA) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 14 brokerage firms.
The average price target for Sabra Healthcare REIT, Inc. (SBRA) is $18.14. The current on short-term price targets is based on 5 reports.
The forecasts for Sabra Healthcare REIT, Inc. (SBRA) range from a low of $15 to a high of $21. The average price target represents a decline of $4.38 from the last closing price of $18.97.
The current DOWNSIDE for Sabra Healthcare REIT, Inc. (SBRA) is 4.38%
Based on short-term price targets offered by 11 analysts, the average price target for Sabra Healthcare comes to $17.86. The forecasts range from a low of $15.00 to a high of $21.00. The average price target represents a decline of 6.98% from the last closing price of $19.20.